Sustained release medicine for artificially inducing sex reversal of grouper and its preparation method
A slow-release drug, grouper-specific technology, applied in the directions of drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, can solve problems such as insufficient mature male fish, avoid polluting water bodies and fish bodies, induce The effect of sexual reversal is stable and reliable, and the effect is highly targeted
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
example 1
[0022] 1. The composition of sustained-release medicine of the present invention
[0023] The composition and proportioning of sustained-release medicine of the present invention are as follows:
[0024] 15 grams of Fadrozole, 75 grams of silastic brand MDX4-4210 medical grade elastomer base (silastic MDX4-4210 medical grade elastomer base), 10 grams of silastic brand MDX4-4210 curing agent .
[0025] 2. The preparation method of slow-release medicine of the present invention
[0026] (1) fully mix the above-mentioned aromatase inhibitor and medical unpolymerized silicone rubber, then add coagulant, and fully mix again;
[0027] (2) Apply vegetable oil on the special formwork with small grooves, press the mixture evenly into the small grooves of the formwork with special tools, and dry under aseptic conditions below 40°C for 24 hours;
[0028] (3) Take out the dried and formed mixture strip with tweezers, and put it in a 4°C refrigerator for storage for later use. Calculat...
example 2
[0032] 1. The composition of sustained-release medicine of the present invention
[0033] The composition and proportioning of sustained-release medicine of the present invention are as follows:
[0034] Vorozole (Vorozole) 1.5 grams, silastic brand MDX4-4210 type medical synthetic rubber base (silastic MDX4-4210 medical grade elastomer base) 90 grams, silastic brand MDX4-4210 type curing agent (silastic MDX4-4210 curing agent) 8.5 grams .
[0035] 2. The preparation method of slow-release medicine of the present invention
[0036] The difference from Example 1 is that the mixture is naturally dried and shaped under aseptic conditions in step (2).
[0037] 3. The use method of sustained-release medicine of the present invention
[0038] The difference from Example 1 is that the dose of aromatase inhibition of 1 mg per kilogram of grouper body weight is implanted, and the drug strip is implanted into the abdomen of female grouper. After operation, 100% of the fish survived....
example 3
[0040] 1. Invention of the composition of sustained-release drugs
[0041] The composition and proportioning of sustained-release medicine of the present invention are as follows:
[0042] Letrozole (Letrozole) 10 grams, silastic brand MDX4-4210 type medical synthetic rubber matrix (silastic MDX4-4210 medical grade elastomer base) 81 grams, silastic brand MDX4-4210 type curing agent (silastic MDX4-4210 curing agent) 9 grams . The above-mentioned letrozole (Letrozole) can also be replaced by formestane (Formestane) or anastrozole (Anastrozole).
[0043] 2. The preparation method of sustained-release medicine of the present invention
[0044] The difference from Example 1 is that the mixture is naturally dried and shaped under aseptic conditions in step (2).
[0045] 3., the use method of sustained-release medicine of the present invention
[0046] The difference from Example 1 is that the dose of aromatase inhibition of 5 mg per kilogram of grouper body weight is implanted,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com